The Combination of SHOX2 and RASSF1A DNA Methylation Had a Diagnostic Value in Pulmonary Nodules and Early Lung Cancer
Oncology · 2024 · 102 (9) · 759-774
DOI: 10.1159/000534275 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology, online erschienen am 23.01.2024. Verfasst von Bin Xie und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Yue Bei People's Hospital, Shaoguan, China. Hauptthemen laut MEDLINE: Biomarkers, Tumor, DNA Methylation, Homeodomain Proteins, Lung Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
Introduction
The study explored the effects of SHOX2 and RASSF1A DNA methylation in lung cancer (LC).
Method
Bronchoalveolar lavage fluid (BALF) samples as well as LC and normal adjacent tissues were collected from 72 LC patients and 35 patients with benign pulmonary nodules. Quantitative analysis of SHOX2 and RASSF1A DNA methylation was performed in benign pulmonary nodules and different stages of LC. The diagnostic value of SHOX2 and RASSF1A DNA methylation in LC and benign pulmonary nodules was determined by receiver operating characteristics analysis. Gain/loss-of-function experiments were constructed in LC cells and mouse models of xenograft and pulmonary nodule metastasis. The levels of SHOX2 and transfer-associated genes were tested through quantitative reverse transcription polymerase chain reaction and Western blot. Malignant phenotype of LC cells was assessed by functional experiment. The tumor volume and weight of mice in xenograft models were measured. Pulmonary nodule metastasis was determined through HE staining assay. 5-azacytidine appeared as a positive control drug.
Result
SHOX2 DNA methylation or RASSF1A DNA methylation had diagnostic efficiency in pulmonary nodules and early LC, with the two combined having better diagnostic value. SHOX2 expression was upregulated in LC. Similar to 5-azacytidine, SHOX2 knockdown inhibited LC cell viability, migration, and invasion in vitro as well as restrained LC tumorigenesis and pulmonary nodule metastasis in vivo, whereas overexpressed SHOX2 had the opposite effects.
Conclusion
The combination of SHOX2 and RASSF1A DNA methylation had a diagnostic value in pulmonary nodules and early LC. SHOX2 positively modulated the tumorigenesis and metastasis of LC by regulating DNA methylation processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Yue Bei People's Hospital, Shaoguan, China.
- Department of Geriatric Medicine, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
- Central Laboratory, Yue Bei People's Hospital, Shaoguan, China.
- Medical Integration and Practice Center of Shandong University, Jinan, China.
Zitieren
APA
Xie, B., Dong, W., He, F., Peng, F., Zhang, H., & Wang, W. (2024). The Combination of SHOX2 and RASSF1A DNA Methylation Had a Diagnostic Value in Pulmonary Nodules and Early Lung Cancer. Oncology, 102(9), 759-774. https://doi.org/10.1159/000534275
Vancouver
Xie B, Dong W, He F, Peng F, Zhang H, Wang W. The Combination of SHOX2 and RASSF1A DNA Methylation Had a Diagnostic Value in Pulmonary Nodules and Early Lung Cancer. Oncology. 2024;102(9):759-774. doi:10.1159/000534275
BibTeX
@article{Xie2024,
author = {Xie, Bin and Dong, Wenyan and He, Fengping and Peng, Feng and Zhang, Honghua and Wang, Wei},
title = {The Combination of SHOX2 and RASSF1A DNA Methylation Had a Diagnostic Value in Pulmonary Nodules and Early Lung Cancer},
journal = {Oncology},
year = {2024},
volume = {102},
number = {9},
pages = {759--774},
doi = {10.1159/000534275}
}
EUVIMED